Fig. 5.From: Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies3D superimposition of VEGFR2 (PDB ID: 4ASD) and FAK (PDB ID: 4K9Y) protein structures with a close focus on the key residues at the ATP binding site (Hydrophobic region: grey; Polar regions: red)Back to article page